Fresenius Medical And Vectren Receive Buy Ratings
Finbox io | Dec 14, 2016 03:24PM ET
Here are today’s top Wall Street analyst ratings where finbox.io’s unbiased fair value estimates support the recommendation.h3 Top Upgrades and Buy Ratings/h3
- JPMorgan Chase reiterated Fresenius Medical Care (NYSE:FMS) at Buy. Shares currently have 20% upside.
- RBC Capital raised its price target for GMS (NYSE:GMS) to $32 per share and set an Outperform rating. Finbox.io’s six valuation analyses also conclude a $32 intrinsic value implying almost 18% upside.
- Piper Jaffray upgraded Kroger (NYSE:KR) from Underweight to Neutral. The new rating is generally supported by the company’s fundamentals.
- Citigroup upgraded Vectren Corp. (NYSE:VVC) from Neutral to Buy. Nine valuation models imply a fair value of $59 per share implying the stock is currently 13% undervalued.
- Sandler O’Neill downgraded Liberty Property Trust (NYSE:LPT) from Hold to Sell. Shares are currently trading at a 11% premium.
- Morgan Stanley downgraded Zayo Group Holdings Inc (NYSE:ZAYO) from Overweight to Equal Weight. Five valuation models imply the stock is 8% overvalued.
Get The News You Want
- William Blair downgraded ICF International Inc (NASDAQ:ICFI) from Outperform to Market Perform. Shares traded lower by nearly 7% following the downgrade. Ten valuation models conclude that the company still has a negative 5% margin of safety.
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.